Abstract P3-15-02: A prospective, open label, non-comparative trial to determine the incidence of chemotherapy-induced nausea and vomiting associated with the docetaxel-cyclophosphamide regimen in early breast cancer patients. Results from the GEICAM 2009-02 study
Keyword(s):
2017 ◽
Vol 49
(6)
◽
pp. 451
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 58
◽
pp. 122-129
◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):